Nebivolol Vida (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Vida, is a beta blocker presented as a tablet for oral use. It treats hypertension and heart failure in adult patients, helping to lower blood pressure and improve cardiac function.

GNH USA supplies Nebivolol Vida as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used in cardiovascular disease management.

- Hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. - Heart failure: improves left‑ventricular ejection fraction and reduces symptoms in chronic heart failure. - Elderly patients with hypertension: provides effective blood‑pressure control with a favorable tolerability profile.

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: especially when standing quickly. - Fatigue: general feeling of tiredness. - Nasal congestion: mild blockage of nasal passages. - Diarrhea: loose stools. - Bradycardia: slower than normal heart rate.

Serious or Rare Side Effects: - Severe bradycardia: heart rate drops to dangerously low levels. - Heart block: impairment of electrical conduction. - Acute heart failure exacerbation. - Bronchospasm: narrowing of airways, especially in asthmatic patients. - Hypotension: sudden, marked drop in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

Before initiating therapy, consider the following safety measures.

- Monitor blood pressure: check regularly to ensure therapeutic targets are met. - Assess heart rate: watch for excessive bradycardia, especially in patients with conduction disorders. - Review cardiac history: avoid in patients with severe sinus bradycardia or second‑degree AV block. - Caution in asthma: beta‑blockade may precipitate bronchospasm. - Adjust in renal impairment: dose may need modification in severe renal dysfunction. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Combined use with non‑selective beta‑blockers: risk of profound bradycardia and hypotension. - Concomitant strong CYP2D6 inhibitors (e.g., paroxetine, quinidine): may increase nebivolol plasma levels. - Co‑administration with calcium‑channel blockers (verapamil, diltiazem): can amplify negative‑inotropic effects.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance antihypertensive effect, requiring blood‑pressure monitoring. - Antihyperglycemic agents: beta‑blockade can mask hypoglycemia symptoms. - NSAIDs: may reduce antihypertensive efficacy. - Antidepressants (tricyclics): may increase risk of cardiac conduction abnormalities.